Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 21/7/2017
SIETES contiene 91904 citas

 
 
 1 a 20 de 599 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Spelsberg A , Prugger C , Doshi P , Ostrowski K , Witte T , Hüsgen D , Keil U , for the Working Group on Health and Working Group on Freedom of Information Transparency International Deutschland eV. Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies. BMJ 2017;356:j337. [Ref.ID 101390]
4.Enlace a cita original Cita con resumen
Hoffmann F, Schmiemann G. Pain medication in German nursing homes: a whole lot of metamizole. Pharmacoepidemiol Drug Saf 2016;25:646-51. [Ref.ID 100394]
5. Cita con resumen
Wise J. Number of children given antidepressants is rising, study shows. BMJ 2016;352:i1457. [Ref.ID 100331]
6.Tiene citas relacionadas Cita con resumen
Kuller LH. Do proton pump inhibitors increase the risk of dementia?. JAMA Neurology 2016;73:379-81. [Ref.ID 100322]
7.Tiene citas relacionadas Cita con resumen
Gomm W, von Holt K, Thomé F, Broich K, Maier W, Fink A, Doblhammer G, Haenisch B. Association of proton pump inhibitors with risk of dementia: a pharmacoepidemiological claims data analysis. JAMA Neurology 2016;73:410-6. [Ref.ID 100299]
8. Cita con resumen
Boseley S. Thalidomide and journalism's golden era. Lancet 2016;387:1151-2. [Ref.ID 100270]
9. Cita con resumen
Purrucker JC, Haas K, Rizos T, Khan S, Wolf M, Hennerici MG, Poli S, Kleinschnitz C, Steiner T, Heuschmann PU, Veltkamp R. Early clinical and radiological course, management, and outcome of intracerebral hemorrhage related to new oral anticoagulants. JAMA Neurology 2016;73:febrero. [Ref.ID 99784]
10. Cita con resumen
Stafford N. German drug industry says pricing law is restricting access to some drugs. BMJ 2015;351:h6205. [Ref.ID 99692]
11. Cita con resumen
Stafford N. Germany considers legalising cannabis for medical use. BMJ 2015;351:h5952. [Ref.ID 99681]
12. Cita con resumen
Naci H, Carter AW, Mossialos E. Why the drug development pipeline is not delivering better medicines. BMJ 2015;351:h5542. [Ref.ID 99639]
13.Enlace a cita original
Barrenberg E, Garbe E. Use of over-the counter (OTC) drugs and perceptions of OTC drug safety among German adults. Eur J Clin Pharmacol 2015;71:1389-96. [Ref.ID 99626]
14. Cita con resumen
Stammschulte T, Ludwig WD, Mühlbauer B, Bronder E, Gundert-Remy U. Metamizole (dipyrone)-associated agranulocytosis. An analysis of German spontaneous reports 1990–2012. Eur J Clin Pharmacol 2015;71:1129-38. [Ref.ID 99553]
15. Cita con resumen
Anónimo. MS finds spending on cancer medications rose 10.3 percent in 2014 to $100 billion. DIA Daily 2015:5 de mayo. [Ref.ID 99029]
17. Cita con resumen
Anónimo. Relatos salvajes del primer mundo. Farmacología virtual 2015;9:1. [Ref.ID 98859]
18.Tiene citas relacionadas Cita con resumen
Köhler M, Haag S, Biester K, Brockhaus AC, McGauran N, Grouven U, Kölsch H, Seay U, Hörn H, Moritz G, Staeck K, Wieseler B. Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports. BMJ 2015;350:h796. [Ref.ID 98850]
19.Tiene citas relacionadas Cita con resumen
Doshi P, Jefferson T. The evidence base for new drugs. BMJ 2015;350:h952. [Ref.ID 98849]
20.Tiene citas relacionadas Cita con resumen
Wieseler B, Wolfrm N, McGauran N, Kerekes MF, Vervölgyi V, Kohlepp P, Kamphuis M, Grouven U. Completeness of reporting of patient-relevant clinical trial outcomes: comparison of unpublished clinical study reports with publicly available data. PLOS Medicine 2013:15 de octubre. [Ref.ID 96365]
Seleccionar todas
 
 1 a 20 de 599 siguiente >>